Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model
Autor: | Seiwa Michihara, Li-Kun Han, Risa Takemoto, Ryuji Takahashi, Takehiro Sejima |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
medicine.medical_specialty Kampo Cell Cycle Proteins Hindlimb Cellular and Molecular Neuroscience Mice Endocrinology Internal medicine medicine Animals Muscle Skeletal Adaptor Proteins Signal Transducing Soleus muscle Mice Inbred ICR Muscle Weakness Endocrine and Autonomic Systems business.industry TOR Serine-Threonine Kinases Muscle weakness General Medicine Organ Size Hindlimb Suspension medicine.disease Muscle atrophy Muscular Disorders Atrophic Diet Muscular Atrophy Neurology Sarcopenia Medicine Kampo medicine.symptom business Hypoactivity Drugs Chinese Herbal |
Zdroj: | Neuropeptides. 90 |
ISSN: | 1532-2785 |
Popis: | Disuse syndrome indicates psychosomatic hypofunction caused by excess rest and motionless and muscle atrophy is termed disuse muscle atrophy. Disuse muscle atrophy-induced muscle weakness and hypoactivity further induces muscle atrophy, leading to a vicious cycle, and this is considered a factor causing secondary sarcopenia and subsequently frailty. Since frailty finally leads to a bedridden state requiring nursing, in facing a super-aging society, intervention for a risk factor of frailty, disuse muscle atrophy, is important. However, the main treatment of disuse muscle atrophy is physical therapy and there are fewer effective preventive and therapeutic drugs. The objective of this study was to search for Kampo medicine with a disuse muscle atrophy-improving effect. Ninjin'yoeito is classified as a qi-blood sohozai (dual supplement) in Chinese herbal medicine, and it has an action supplementing the spleen related to muscle. In addition, improvement of muscle mass and muscle weakness by ninjin'yoeito in a clinical study has been reported. In this study, the effect of ninjin'yoeito on disuse muscle atrophy was investigated. A disuse muscle atrophy model was prepared using male ICR mice. After surgery applying a ring for tail suspension, a 1-week recovery period was set. Ninjin'yoeito was administered by mixing it in the diet for 1 week after the recovery period, followed by tail suspension for 14 days. Ninjin'yoeito administration was continued until autopsy including the hindlimb suspension period. The mice were euthanized and autopsied immediately after completion of tail suspension, and the hindlimb muscles were collected. The food and water intakes during the hindlimb unloaded period, wet weight of the collected muscle, and muscle synthesis and muscle degradation-related factors in blood and muscle were evaluated. Ingestion of ninjin'yoeito inhibited tail suspension-induced reduction of the soleus muscle wet weight. In addition, an increase in the blood level of a muscle synthesis-related factor, IGF-1, and promotion of phosphorylation of mTOR and 4E-BP1 in the soleus muscle were observed. It was suggested that ninjin'yoeito has a disuse muscle atrophy-improving action. Promotion of the muscle synthesis pathway was considered the action mechanism of this. |
Databáze: | OpenAIRE |
Externí odkaz: |